UAB Lung Health Center
Birmingham, Alabama, 35233, United States
Location status: Recruiting
NCT Number: NCT06925373
This project will compare the health effects of public housing renovation, neighborhood built and social environment improvements, and indoor air purification, alone and in combination, as well as the cost effectiveness of each approach.
STUDY 1: The study will assess the effects of public housing and neighborhood environment (built and social) improvements on health-related behaviors, psychosocial and physiologic stress, and self-reported and physiological markers of lung health and chronic disease.
STUDY 2: The study will determine whether indoor air purification can positively impact lung health in public housing sites not undergoing housing renovation, comparing a site near industrial pollution vs one less contaminated.
Interested in participating?
Request Info18 year–89 year
All sexes
Interventional
Not applicable
Birmingham, Alabama, 35233, United States
Location status: Recruiting
Participants will complete surveys, physical exam, lung function tests, and blood draw. An indoor air purifier with a usage tracker and an indoor air quality monitor will be provided, and used filters will be analyzed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An indoor air purifier with a dual HEPA/activated carbon filter, a usage tracker, and an indoor air quality monitor will be installed in public housing residences.
Other names: Coway Airmega 400
Improved built environment (green space, sidewalks, street lights) and social environment (educational and workforce development programs, wrap-around social services, Internet access).
High-quality public housing
Time frame: Baseline, 12 months, 24 months
A self-reported measure of physical, mental, and social health. 10 item questionnaire T-score metric from zero to 100 where higher T-scores indicate better health.
Time frame: Baseline, 12 months
Measure of cumulative stress burden as the number of 10 indicators above a threshold: (1) serum albumin <3.8 g/dL, (2) C Reactive Protein (CRP) >3 mg/L, (3) High-Density Lipoprotein (HDL) <40 mg/dL, (4) total cholesterol ≥240 mg/dL, (5) heart rate ≥90 beats/min, (6) systolic Blood Pressure (BP) ≥140 mmHg, (7) diastolic BP ≥90 mmHg, (8) serum creatinine ≥1.3 mg/dL, (9) Blood Urea Nitrogen (BUN) ≥18 mg/dL, and (10) waist circumference >88 cm in women, >102 cm in men.
Time frame: Baseline, 6 months, 12 months (Study 2 only)
Particulate matter (PM2.5). Measures particles in the air that are 2.5 micrometers or smaller in diameter.
Time frame: Baseline, 6 months, 12 months (Study 2 only)
FEV1/FVC. A measure of lung funtion that compares the amount of air exhaled in the first second (FEV1) to the total amount of air exhaled in a forced breath (FVC).
Contact information is provided by the study sponsor or research team.
Gabriela R Oates, PhD
CONTACT
Joy R Ledvina, Program Director, MBA
CONTACT
University of Alabama at Birmingham
Other
Housing, Environment, And Living Conditions for Transformed Health (HEALTHe Birmingham)
Acronym: HEALTHe
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03721952
Brain Diseases, Brain Injuries
Seattle, Washington, United States
View Trial DetailsNCT04666558
Behavior, Cancer
Edmonton, Alberta, Canada
View Trial DetailsNCT06177717
Lung Diseases, Respiratory Tract Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05922761
Bronchial Diseases, Bronchiolitis
Stanford, California, United States
View Trial Details